ストックスクリーナーアプリを入手
3.27
4.11%
-0.14
アフターアワーズ：
3.27
前日終値:
$3.41
開ける：
$3.33
24時間の取引高:
175.75K
Relative Volume:
0.44
時価総額：
$163.63M
収益：
$17.63M
当期純損益:
$-57.71M
株価収益率:
-2.2095
EPS:
-1.48
ネットキャッシュフロー:
$-60.45M
1週間 パフォーマンス:
-5.22%
1か月 パフォーマンス:
-9.67%
6か月 パフォーマンス:
-25.17%
1年 パフォーマンス:
-38.53%
1日の値動き範囲:
$3.26
$3.40
1週間の範囲:
$3.09
$3.52
52週間の値動き範囲:
$3.075
$6.54
Scpharmaceuticals Inc Stock (SCPH) Company Profile
名前
Scpharmaceuticals Inc
セクター
電話
617-517-0730
住所
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
SCPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
3.27 | 163.63M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.16 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.07 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
657.97 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.25 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
119.94 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | Craig Hallum | Buy |
| 2022-12-01 | 開始されました | Cowen | Outperform |
| 2022-10-21 | 再開されました | Jefferies | Buy |
| 2022-10-11 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-02 | 開始されました | Maxim Group | Buy |
| 2021-09-09 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-10-15 | 開始されました | H.C. Wainwright | Buy |
| 2019-01-30 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
すべてを表示
Scpharmaceuticals Inc (SCPH) 最新ニュース
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - The Manila Times
Upcoming Catalyst: scPharmaceuticals Reveals Key Strategic Updates at Major Healthcare Conference - StockTitan
King Luther Capital Management Corp Increases Stake in scPharmaceuticals Inc - GuruFocus.com
Jane Street Group LLC Reduces Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Provides Preliminary Financial Results for Fourth Quarter and Full Year 2024On January 10, 2025, scPharmaceuticals Inc. (NASDAQ: SCPH) released an 8-K filing containing preliminary unaudited financial information for the quarter and - Defense World
scPharmaceuticals projects 99% Q4 revenue jum - Investing.com
scPharmaceuticals projects 99% Q4 revenue jum By Investing.com - Investing.com South Africa
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
scPharmaceuticals Reports Explosive 167% Revenue Growth, FUROSCIX Shipments Hit Record High - StockTitan
Barclays PLC Has $186,000 Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Geode Capital Management LLC - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by State Street Corp - Defense World
scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit - Yahoo Finance
Sanctuary Advisors LLC Takes $75,000 Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
27,169 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by XTX Topco Ltd - Defense World
BNP Paribas Financial Markets Has $26,000 Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Charles Schwab Investment Management Inc. Sells 3,312 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SC Pharmaceuticals Inc (SCPH-Q) QuotePress Release - The Globe and Mail
The Manufacturers Life Insurance Company Invests $57,000 in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
2 "Strong Buy"-Rated Biotech Stocks With 303% To 446% Upside Potential - Barchart
Tscan Therapeutics Inc (TCRX-Q) QuotePress Release - The Globe and Mail
Head to Head Survey: Cyclerion Therapeutics (NASDAQ:CYCN) vs. scPharmaceuticals (NASDAQ:SCPH) - Defense World
Wearable Injector Market Growth in Future Scope 2024-2031 | - openPR
ScPharmaceuticals Stock Falls After Noting Possible FDA Submission Delay - MarketWatch
MetLife Investment Management LLC Grows Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SCPH (scPharmaceuticals) 9-Day RSI : 45.28 (As of Dec. 04, 2024) - GuruFocus.com
Jefferies cuts scPharmaceuticals stock target, keeps buy rating on Q3 results - Investing.com UK
Suvretta Capital Management LLC Makes New $9.34 Million Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
Rubric Capital Management LP Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
scPharmaceuticals (STU:2SX) Cash Flow from Operations : €-64.68 Mil (TTM As of Sep. 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Float Percentage Of Total Shares Outstanding : 88.47% (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Intrinsic Value: Projected FCF : €-6.70 (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term - Simply Wall St
HC Wainwright Expects Reduced Earnings for scPharmaceuticals - MarketBeat
King Luther Capital Management Corp's Strategic Acquisition in s - GuruFocus.com
Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
500: Something went wrong - Investing.com India
SCPH stock touches 52-week low at $3.24 amid market challenges - Investing.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript - Insider Monkey
scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
The one-year earnings decline has likely contributed toscPharmaceuticals' (NASDAQ:SCPH) shareholders losses of 33% over that period - Simply Wall St
Earnings call: scPharmaceuticals reports robust Q3 growth, eyes FDA nod By Investing.com - Investing.com UK
ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates - MSN
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
scPharmaceuticals Reports Strong Growth in Q3 2024 - TipRanks
ScPharmaceuticals Q3 Loss Widens, Revenue Rises - Marketscreener.com
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
scPharmaceuticals' FUROSCIX Revenue Surges 164% YoY to $10M in Q3, Expands FDA Approval | SCPH Stock News - StockTitan
Certain Common Stock of scPharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2024. - Marketscreener.com
Scpharmaceuticals Inc (SCPH) 財務データ
収益
当期純利益
現金流量
EPS
0.82%
0.53%
大文字化:
|
ボリューム (24 時間):